BREAKING
BETA Technologies Reports Wider Q4 Loss of $1.71/Share vs $0.47 Estimate, Guides 2026 Revenue to $130M-$135M 3 minutes ago Yalla Group (YALA) Reports Q4 EPS of $0.20 as Revenue Stalls at $83.9M 26 minutes ago FuelCell Energy (FCEL) Q1 Loss Narrows to $0.52/Share vs $0.68 Estimate; Revenue Misses by 30% 36 minutes ago Yext (YEXT) Q4 Earnings: $0.15 EPS as Revenue Flatlines at $112M 37 minutes ago Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share 17 hours ago Korn Ferry (KFY) Q3 Earnings Beat: EPS Rises 7.6% to $1.28 on 7.2% Revenue Growth 17 hours ago RNAC CEO Carsten Brunn Sells 23,766 Shares at $6.82, Retains 323,530 Shares 17 hours ago Repay (RPAY) Reports $0.24 Adjusted EPS on $77.7M Revenue, Posts $6.6M GAAP Loss 17 hours ago CMCT Reports Q4 Loss of $11.20/Share 18 hours ago ACCO Brands adjusted earnings per share of $0.38 for Q4 2025 18 hours ago BETA Technologies Reports Wider Q4 Loss of $1.71/Share vs $0.47 Estimate, Guides 2026 Revenue to $130M-$135M 3 minutes ago Yalla Group (YALA) Reports Q4 EPS of $0.20 as Revenue Stalls at $83.9M 26 minutes ago FuelCell Energy (FCEL) Q1 Loss Narrows to $0.52/Share vs $0.68 Estimate; Revenue Misses by 30% 36 minutes ago Yext (YEXT) Q4 Earnings: $0.15 EPS as Revenue Flatlines at $112M 37 minutes ago Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share 17 hours ago Korn Ferry (KFY) Q3 Earnings Beat: EPS Rises 7.6% to $1.28 on 7.2% Revenue Growth 17 hours ago RNAC CEO Carsten Brunn Sells 23,766 Shares at $6.82, Retains 323,530 Shares 17 hours ago Repay (RPAY) Reports $0.24 Adjusted EPS on $77.7M Revenue, Posts $6.6M GAAP Loss 17 hours ago CMCT Reports Q4 Loss of $11.20/Share 18 hours ago ACCO Brands adjusted earnings per share of $0.38 for Q4 2025 18 hours ago
LXRX

Lexicon Pharmaceuticals, inc

$LXRX NASDAQ Jul 30, 2021 BMO Q2 2021

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

LXRX Coverage

News Lexicon Pharmaceuticals (LXRX) Q4 Loss Narrows to $0.04 Per Share Despite 79% Revenue Plunge to $5.5M Mar 6, 2026 News LXRX Reports Mixed Q4 Results: Loss Improves to $0.04 Per Share But Revenue Crashes 79% YoY Mar 6, 2026 Event Lexicon Pharmaceuticals, inc (LXRX) Q2 2022 Earnings Call Aug 1, 2022 Event Lexicon Pharmaceuticals, inc (LXRX) Q1 2022 Earnings Call May 2, 2022 Event Lexicon Pharmaceuticals, inc (LXRX) Q3 2021 earnings conference call Nov 8, 2021 Transcript Lexicon Pharmaceuticals (NASDAQ: LXRX) Q1 2020 Earnings Call Transcript Apr 27, 2020